Related Experiment Video
Updated: May 6, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis
Abstract:
ROS are implicated in bone diseases. NADPH oxidase 4 (NOX4), a constitutively active enzymatic source of ROS, may contribute to the development of such disorders. Therefore, we studied the role of NOX4 in bone homeostasis. Nox4(-/-) mice displayed higher bone density and reduced numbers and markers of osteoclasts. Ex vivo, differentiation of monocytes into osteoclasts with RANKL and M-CSF induced Nox4 expression. Loss of NOX4 activity attenuated osteoclastogenesis, which was accompanied by impaired activation of RANKL-induced NFATc1 and c-JUN. In an in vivo model of murine ovariectomy–induced osteoporosis, pharmacological inhibition or acute genetic knockdown of Nox4 mitigated loss of trabecular bone. Human bone obtained from patients with increased osteoclast activity exhibited increased NOX4 expression. Moreover, a SNP of NOX4 was associated with elevated circulating markers of bone turnover and reduced bone density in women. Thus, NOX4 is involved in bone loss and represents a potential therapeutic target for the treatment of osteoporosis.
Insights
NADPH oxidase 4 (NOX4) drives bone loss by promoting osteoclast activity. Inhibiting NOX4 in osteoporosis models improved bone density, suggesting NOX4 as a therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Reactive oxygen species (ROS) are linked to bone diseases.
- NADPH oxidase 4 (NOX4) is a key source of ROS and may contribute to bone disorders.
Purpose of the Study:
- To investigate the role of NOX4 in maintaining bone homeostasis.
- To explore NOX4 as a potential therapeutic target for osteoporosis.
Main Methods:
- Studied Nox4(-/-) mice for bone density and osteoclast markers.
- Analyzed osteoclast differentiation ex vivo and in vivo models of osteoporosis.
- Assessed NOX4 expression in human bone samples and correlated a NOX4 SNP with bone density.
Main Results:
- Nox4(-/-) mice showed increased bone density and fewer osteoclasts.
- NOX4 deficiency impaired osteoclastogenesis by inhibiting RANKL-induced NFATc1 and c-JUN activation.
- Pharmacological or genetic NOX4 inhibition protected against ovariectomy-induced bone loss.
- Human bone with high osteoclast activity and a NOX4 SNP showed increased NOX4 expression and reduced bone density.
Conclusions:
- NOX4 plays a significant role in bone homeostasis and osteoclast function.
- NOX4 is implicated in bone loss associated with osteoporosis.
- Targeting NOX4 presents a promising therapeutic strategy for treating osteoporosis.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...

